Powering the transformation of cancer research
Solving the puzzle of cancer

Brain Cancer
Gliomas can occur in the brain and in various locations in the nervous system, including the brain stem and spinal column. Some tumors, after several months, become treatment resistant. TCF researchers are looking at the mechanisms behind this resistance.

Breast Cancer
Our researchers are exploring different avenues to potentially more effective breast cancer treatments through hormone identification, radiation and immunotherapies, and the isolation of gene markers.

GI Cancers
The relationship between irritable bowel disease and cancer has complicated treatment for patients. Our researchers are clarifying the approach.

Hematological Cancer
Blood cancers can be very resistant to treatment. Our researchers are tackling some of the basic science behind some of the genetic markers in order to find better treatments.

Hodgkin's and Non-Hodgkin's Lymphomas
Our researchers are finding breakthroughs in the treatment of these lymphatic system cancers that show promise for solid tumors as well.

Leukemia
We are backing basic research into the complex interactions and molecular pathways behind leukemia in both adults and children.

Malignant Melanomas
Exploring how the immune system does and doesn’t respond when there are genetic variations can help identify effective treatments in the future.
Backing innovation for over 50 years
Stay connected
2024 Innovation Gala →
Our 2024 Innovation Gala shone a spotlight on the incredible strides in cancer research and patient care.
News and Updates →
From recent discoveries from our board members and research grantees, to events you can join. Stay up to date on what's happening in our TCF community.
Breast Cancer
with Dr. Sandra Demaria →
with Dr. Sandra Demaria →
We paid a visit to one of our grantees, Dr. Sandra Demaria, a Professor of Radiation Oncology and a Professor of Pathology at Weill Cornell Medicine, and had the pleasure of getting an inside look at some of the work her lab are doing in Breast Cancer.
Partnering institutions
Our Board of Trustees, Medical Directors, and Grantees are affiliated with leading research institutions in New York, New Jersey and Connecticut.










